Wellbutrin (bupropion--and also marketed as Zyban, Voxra, Budeprion, or Aplenzin) is a popular anti-depressant drug throughout the US. In a study conducted from 1997-2004, it was discovered that women who took Wellbutrin while pregnant had a more than double risk of having a child with a serious heart defect, among other problems. Within the product labeling for Wellbutrin, there is no warning of increased risks of birth defects. If you know an infant suffering from birth defects after the mother used Wellbutrin, the lawyers at Rheingold Giuffra Ruffo & Plotkin LLP are here to help you explore your legal options.
At Rheingold Giuffra Ruffo & Plotkin LLP, we have been helping people from New York and across the nation with their most critical legal problems for over 30 years. We are handling a wide range of drug liability claims, including those involving the prescription drugs which are implicated with birth defects.
The American Journal of Obstetrics and Gynecology reports that two out of every 1,000 women who took Wellbutrin during pregnancy will have a child with birth defects. The implicated abnormalities included:
- Heart ventricular outflow tract defects
- Artial septal defects
- Persistent pulmonary hypertension
- Ventrical septal defects
- Hypoclastic left heart
- Coartication of the aorta
- Lung defects
- Pulmonary stenosis
Our attorneys will work with you personally to determine the extent of the monetary damage this drug has caused you, and what legal remedies are at your disposal. Our goal is to help you obtain monetary compensation for the financial hardships you face.